The low fasting serum C‐peptide level was associated with reduced sural nerve action potential amplitudes: A cross‐sectional study of Japanese type 2 diabetes
Аннотация
ABSTRACT Aims/Introduction The association between the fasting serum C‐peptide levels and diabetic polyneuropathy (DPN) in patients with type 2 diabetes remains controversial. Furthermore, the association with the electrophysiological parameters of nerve conduction studies (NCS) has not been elucidated. Therefore, we investigated whether the fasting serum C‐peptide levels are associated with nerve conduction velocity (CV) and action potential amplitude (Amp) in patients with type 2 diabetes. Materials and Methods This retrospective cross‐sectional study enrolled outpatients with type 2 diabetes who underwent the DPNCheck® at the Higashikurume Ekimae Clinic in Tokyo, Japan, between March 1, 2016, and June 30, 2025. Participants were categorized into tertiles according to their fasting serum C‐peptide levels. Abnormal values of CV and Amp were defined as CV <46.5 m/s and Amp <10.5 μV. A logistic regression analysis was used to evaluate whether the fasting serum C‐peptide levels were associated with CV and Amp abnormalities. Results One‐hundred thirty‐one participants were included and stratified into tertiles based on fasting serum C‐peptide levels: Tertile 1, ≤1.9 ng/mL; Tertile 2, 2.0–2.8 ng/mL; and Tertile 3, ≥2.9 ng/mL. Tertile 1 was independently associated with an abnormal Amp (odds ratio: 5.08, 95% confidence interval: 1.41–18.4), whereas no independent association was observed with an abnormal CV. Tertile 2 was not associated with an abnormal CV or Amp. Additionally, a nonlinear relationship was observed between the fasting serum C‐peptide levels and an abnormal Amp. Conclusions Low fasting serum C‐peptide levels were independently associated with abnormal Amp in patients with type 2 diabetes.